Information  X 
Enter a valid email address

UDG Healthcare Plc (UDG)

  Print      Mail a friend       Annual reports

Wednesday 01 July, 2020

UDG Healthcare Plc

Block listing Interim Review

RNS Number : 6875R
UDG Healthcare Public Limited Co.
01 July 2020
 

BLOCK LISTING SIX MONTHLY RETURN

 

 

 

 

 

Date: 1 July 2020

 

Name of applicant:

UDG HEALTHCARE PLC

Name of scheme:

UNITED DRUG PLC EXECUTIVE SHARE OPTION PLAN

Period of return:

From:

1 JANUARY 2020

To:

30 JUNE 2020

Balance of unallotted securities under scheme(s) from previous return:

332,927

 

Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:   Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

131,827

Equals:   Balance under scheme(s) not yet issued/allotted at end of period:

201,100

         

 

Name of contact:

Damien Moynagh

Telephone number of contact:

+ 353 1 468 9000

 

 

 

 

 

 

 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

 

 

Date: 1 July 2020

 

Name of applicant:

UDG HEALTHCARE PLC

Name of scheme:

UNITED DRUG PLC LONG TERM INCENTIVE PLAN

Period of return:

From:

1 JANUARY 2020

To:

30 JUNE 2020

Balance of unallotted securities under scheme(s) from previous return:

2,859,842

Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:   Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

726,304

Equals:   Balance under scheme(s) not yet issued/allotted at end of period:

2,133,538

         

 

Name of contact:

Damien Moynagh

Telephone number of contact:

+ 353 1 468 9000

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BLRGIGDRLGGDGGB

a d v e r t i s e m e n t